Patents by Inventor Yoon Oh

Yoon Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL SOLID DOSE FORMULATIONS
    Publication number: 20240366511
    Abstract: Disclosed are novel pharmaceutical compositions comprising gepotidacin, such as gepotidacin mesylate dihydrate, gepotidacin mesylate anhydrate or gepotidacin anhydrate. The present disclosure also provides methods for making the pharmaceutical composition comprising gepotidacin, and methods of treating bacterial infections using such pharmaceutical composition.
    Type: Application
    Filed: February 3, 2022
    Publication date: November 7, 2024
    Inventors: Chandan BHUGRA, Shavari BORKAR, Yoon OH, Rennan PAN
  • Formulations for intravenous administration
    Patent number: 10945947
    Abstract: The present invention relates to an improved formulation of danirixin in its hydrobromide salt form. This improved formulation can be an aqueous intravenous formulation containing danirixin or a lyophilized pharmaceutical solid composition containing danirixin to be reconstituted to provide a solution for intravenous administration.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: March 16, 2021
    Inventors: Rachel Apfelbaum, Andrew James Peat, Yoon Oh
  • FORMULATIONS FOR INTRAVENOUS ADMINISTRATION
    Publication number: 20200206129
    Abstract: The present invention relates to an improved formulation of danirixin in its hydrobromide salt form. This improved formulation can be an aqueous intravenous formulation containing danirixin or a lyophilized pharmaceutical solid composition containing danirixin to be reconstituted to provide a solution for intravenous administration.
    Type: Application
    Filed: December 3, 2019
    Publication date: July 2, 2020
    Inventors: Rachel Apfelbaum, Andrew James Peat, Yoon Oh
  • FORMULATIONS FOR INTRAVENOUS ADMINISTRATION
    Publication number: 20180369135
    Abstract: The present invention relates to an improved formulation of danirixin in its hydrobromide salt form. This improved formulation can be an aqueous intravenous formulation containing danirixin or a lyophilized pharmaceutical solid composition containing danirixin to be reconstituted to provide a solution for intravenous administration.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 27, 2018
    Inventors: Rachel APFELBAUM, Andrew James PEAT, Yoon OH
  • Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
    Publication number: 20040166162
    Abstract: The subject invention is multi layer pharmaceutical dosage form comprising at least two layers whereby a proton pump inhibitor is in one distinct layer and an aluminum, magnesium or calcium antacid salt is in a second distinct layer.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 26, 2004
    Inventors: Robert Niecestro, Unchalee Kositprapa, Yoon Oh, Avinash Nangia, John R. Cardinal, Elliot F. Hahn